Optiver Holding
LFCR icon

Optiver Holding’s Lifecore Biomedical LFCR Stock Holding History

Optiver Holding’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126 Sell
24
-224
-90% -$1.13K ﹤0.01% 2635
2026
Q1 		$923 Sell
248
-216
-47% -$1.49K ﹤0.01% 2073
2025
Q4 		$3.8K Hold
464
– – ﹤0.01% 1569
2025
Q3 		$3.42K Buy
+464
New +$3.51K ﹤0.01% 2082

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Optiver Holding's LFCR Position: Q2 2026 in Review

Optiver Holding reduced its Lifecore Biomedical (LFCR) stake by 90% in Q2 2026, selling an estimated $1.13K and leaving 24 shares worth $126. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Optiver Holding first reported a position in LFCR in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.8K in Q4 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Optiver Holding held 24 shares of Lifecore Biomedical worth $126 as of Q2 2026.
  • Optiver Holding sold 224 Lifecore Biomedical shares in Q2 2026, an estimated $1.13K.
  • Lifecore Biomedical made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2635 holding.
  • Optiver Holding first reported a position in Lifecore Biomedical in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Lifecore Biomedical position peaked at $3.8K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.